233 related articles for article (PubMed ID: 20492709)
1. A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.
Meyniel JP; Cottu PH; Decraene C; Stern MH; Couturier J; Lebigot I; Nicolas A; Weber N; Fourchotte V; Alran S; Rapinat A; Gentien D; Roman-Roman S; Mignot L; Sastre-Garau X
BMC Cancer; 2010 May; 10():222. PubMed ID: 20492709
[TBL] [Abstract][Full Text] [Related]
2. Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome.
Barry WT; Kernagis DN; Dressman HK; Griffis RJ; Hunter JD; Olson JA; Marks JR; Ginsburg GS; Marcom PK; Nevins JR; Geradts J; Datto MB
J Clin Oncol; 2010 May; 28(13):2198-206. PubMed ID: 20368555
[TBL] [Abstract][Full Text] [Related]
3. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
[TBL] [Abstract][Full Text] [Related]
4. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.
Joosse SA; Brandwijk KI; Devilee P; Wesseling J; Hogervorst FB; Verhoef S; Nederlof PM
Breast Cancer Res Treat; 2012 Apr; 132(2):379-89. PubMed ID: 20614180
[TBL] [Abstract][Full Text] [Related]
5. Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions.
Davidson B; Stavnes HT; Holth A; Chen X; Yang Y; Shih IeM; Wang TL
J Cell Mol Med; 2011 Mar; 15(3):535-44. PubMed ID: 20132413
[TBL] [Abstract][Full Text] [Related]
6. Robust multi-tissue gene panel for cancer detection.
Irgon J; Huang CC; Zhang Y; Talantov D; Bhanot G; Szalma S
BMC Cancer; 2010 Jun; 10():319. PubMed ID: 20569444
[TBL] [Abstract][Full Text] [Related]
7. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.
Bollet MA; Servant N; Neuvial P; Decraene C; Lebigot I; Meyniel JP; De Rycke Y; Savignoni A; Rigaill G; Hupé P; Fourquet A; Sigal-Zafrani B; Barillot E; Thiery JP
J Natl Cancer Inst; 2008 Jan; 100(1):48-58. PubMed ID: 18159071
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
[TBL] [Abstract][Full Text] [Related]
9. Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Bonnefoi H; Potti A; Delorenzi M; Mauriac L; Campone M; Tubiana-Hulin M; Petit T; Rouanet P; Jassem J; Blot E; Becette V; Farmer P; André S; Acharya CR; Mukherjee S; Cameron D; Bergh J; Nevins JR; Iggo RD
Lancet Oncol; 2007 Dec; 8(12):1071-1078. PubMed ID: 18024211
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide single nucleotide polymorphism arrays as a diagnostic tool in patients with synchronous endometrial and ovarian cancer.
Ikeda Y; Oda K; Nakagawa S; Murayama-Hosokawa S; Yamamoto S; Ishikawa S; Wang L; Takazawa Y; Maeda D; Wada-Hiraike O; Kawana K; Fukayama M; Aburatani H; Yano T; Kozuma S; Taketani Y
Int J Gynecol Cancer; 2012 Jun; 22(5):725-31. PubMed ID: 22635024
[TBL] [Abstract][Full Text] [Related]
11. A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.
Ostrovnaya I; Olshen AB; Seshan VE; Orlow I; Albertson DG; Begg CB
Stat Med; 2010 Jul; 29(15):1608-21. PubMed ID: 20205270
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.
Wamunyokoli FW; Bonome T; Lee JY; Feltmate CM; Welch WR; Radonovich M; Pise-Masison C; Brady J; Hao K; Berkowitz RS; Mok S; Birrer MJ
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):690-700. PubMed ID: 16467078
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.
Olawaiye A; Caesar L; Walsh D; Lyman M; Yeh J; Rodabaugh K; Marchetti D; Lele S; Odunsi K
Gynecol Oncol; 2004 Sep; 94(3):796-802. PubMed ID: 15350375
[TBL] [Abstract][Full Text] [Related]
14. Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma.
Na K; Lee JY; Sung JY; Kim GM; Koo JS; Kim HS
Virchows Arch; 2018 Aug; 473(2):165-175. PubMed ID: 29926183
[TBL] [Abstract][Full Text] [Related]
15. [Metastatic tumors in the ovary, difficulties of histologic diagnosis].
Tamás J; Vereczkey I; Tóth E
Magy Onkol; 2015 Sep; 59(3):205-13. PubMed ID: 26339910
[TBL] [Abstract][Full Text] [Related]
16. Characterization of adjacent breast tumors using oligonucleotide microarrays.
Unger MA; Rishi M; Clemmer VB; Hartman JL; Keiper EA; Greshock JD; Chodosh LA; Liebman MN; Weber BL
Breast Cancer Res; 2001; 3(5):336-41. PubMed ID: 11597324
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles of primary breast tumors maintained in distant metastases.
Weigelt B; Glas AM; Wessels LF; Witteveen AT; Peterse JL; van't Veer LJ
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15901-5. PubMed ID: 14665696
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
[TBL] [Abstract][Full Text] [Related]
19. Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease.
Modlich O; Prisack HB; Munnes M; Audretsch W; Bojar H
Clin Cancer Res; 2004 Oct; 10(19):6418-31. PubMed ID: 15475428
[TBL] [Abstract][Full Text] [Related]
20. Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number.
Andrews J; Kennette W; Pilon J; Hodgson A; Tuck AB; Chambers AF; Rodenhiser DI
PLoS One; 2010 Jan; 5(1):e8665. PubMed ID: 20084286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
